Millionaire drug Zolgensma poses threat to HMOs in Brazil

Super-expensive gene therapy Zolgensma is now on the mandatory coverage list for Brazil's private health insurance plans.

Related Keywords

Brazil , ,Brazil Health Ministry ,Brazil National Supplementary Health Agency ,National Supplementary Health Agency ,Health Ministry ,